Article
Dr. Niteesh Choudhry, Associate Professor, Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics in Boston, discusses VBID and how looming questions revealed from this study show the model’s importance as well as its need to be better defined.
Dr. Choudhry explains that a key method to better defining VBID is to conduct similar studies within other specialties to learn about outcomes when the model is applied to diseases such as diabetes, hypertension, and hyperlipidemia.